- MACD is crossing MACD signal line at 1.4. MACD crossing signal line is bullish signal.
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes fromFinra
Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Healthcare services provider Accolade Inc said on Thursday it would buy telehealth startup 2nd.MD for about $460 million to double its addressable market and tap into growing demand for virtual services. Accolade's shares rose 7.4% in extended trading. The unrelenting surge in coronavirus cases and social distancing measures implemented to control the pandemic have prompted people to turn to virtual consultation and treatment offerings.
Accolade Inc. said late Thursday it has agreed to buy Innovation Specialists LLC, which does business as 2nd.MD, a "leading" expert medical opinion and medical decision support company based in Houston, for $460 million. The deal is expected to close by the end of February, and under the terms of the agreement, Accolade will pay $230 million in cash, $130 million in Accolade stock, and up to $100 million of Accolade stock payable upon certain revenue milestones after the closing. "With healthcar...
Accolade to Acquire 2nd.MD Accolade announces intent to acquire 2nd.MD, a Houston, Texas, based Expert Medical Opinion company.The addition of 2nd.MD’s Expert Medical Opinion services to Accolade’s portfolio of high-touch, technology-enabled health and benefits solutions expands Accolade’s clinical capabilities and creates the market’s most comprehensive, integrated healthcare navigation experience.SEATTLE, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD), which provides personal...
SEATTLE, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, will participate in the 39th Annual J.P. Morgan Healthcare Conference, including a presentation on Thursday, January 14, 2021 at 2:50 p.m. E.T. An audio webcast and related presentation materials will be available at ir.accolade.com. About Accolade, Inc.Acc...
ACCD earnings call for the period ending December 31, 2020.